Search Results - "Stuyt, P. M. J."

Refine Results
  1. 1
  2. 2

    Improved competence after a palliative care course for internal medicine residents by Mulder, SF, Bleijenberg, G, Verhagen, SC, Stuyt, PMJ, Schijven, MP, Tack, CJ

    Published in Palliative medicine (01-06-2009)
    “…Residents report that they received inadequate teaching in palliative care and low levels of comfort and skills when taking care of dying patients. This study…”
    Get full text
    Journal Article
  3. 3

    Long-term effects of simvastatin in familial dysbetalipoproteinaemia by Stuyt, P M, Mol, M J, Stalenhoef, A F

    Published in Journal of internal medicine (01-08-1991)
    “…The long-term effects (66 weeks) of simvastatin (40 mg in one or two doses per day), an inhibitor of HMG CoA-reductase, were evaluated in 12 patients with…”
    Get more information
    Journal Article
  4. 4

    Who does become an internist? by STUYT, P. M. J, DE GRAAF, J, VAN DER MEER, J. W. M

    Published in Netherlands journal of medicine (01-03-2004)
    “…Internal medicine is a broad medical speciality and choosing the residency programme opens up a variety of career tracks. Despite this broad choice of…”
    Get full text
    Journal Article
  5. 5

    Why don't medical textbooks teach? The lack of logic in the differential diagnosis by STUYT, P. M. J, DE VRIES ROBBE, P. F, VAN DER MEER, J. W. M

    Published in Netherlands journal of medicine (01-11-2003)
    “…Medical textbooks are an important aid in the process of diagnosing and treating patients. Medical students use these books to acquire the skills necessary for…”
    Get full text
    Journal Article
  6. 6

    Increased removal of remnants of triglyceride-rich lipoproteins on a diet rich in polyunsaturated fatty acids by Demacker, P N, Reijnen, I G, Katan, M B, Stuyt, P M, Stalenhoef, A F

    Published in European journal of clinical investigation (01-04-1991)
    “…We studied the effect of two diets, one rich in polyunsaturated and the other in saturated fatty acids, on the postprandial processing of exogenous and…”
    Get more information
    Journal Article
  7. 7

    Treatment of primary hypercholesterolaemia. Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study by Stalenhoef, A F, Lansberg, P J, Kroon, A A, Kortmann, B, De Haan, A F, Stuyt, P M, Kastelein, J J

    Published in Journal of internal medicine (01-07-1993)
    “…To compare the efficacy and safety of increasing doses (0, 10, 20 and 40 mg day-1, each dose for 6 weeks) of the inhibitors of 3-hydroxy-3-methylglutaryl…”
    Get more information
    Journal Article
  8. 8

    Effects of inhibition of cholesterol synthesis by simvastatin on the production of adrenocortical steroid hormones and ACTH by Mol, M J, Stalenhoef, A F, Stuyt, P M, Hermus, A R, Demacker, P N, Van 'T Laar, A

    Published in Clinical endocrinology (Oxford) (01-12-1989)
    “…Simvastatin, a derivative of lovastatin, is a potent inhibitor of cholesterol biosynthesis and may interfere with steroid hormone production, for which…”
    Get more information
    Journal Article
  9. 9

    A study of the hypolipidemic effect of estrogen in type III hyperlipoproteinemia by Stuyt, P M, Demacker, P N, van't Laar, A

    Published in Hormone and metabolic research (01-09-1986)
    “…Ethinylestradiol (1 microgram/kg/day during 15 days) resulted in a gradual decrease of serum cholesterol, serum triglycerides (TG), very low density…”
    Get more information
    Journal Article
  10. 10

    Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease by Stuyt, P M, Brenninkmeijer, B J, Demacker, P N, Hendriks, J C, van Elteren, P, Stalenhoef, A F, van 't Laar, A

    “…To determine the influence of the apolipoprotein E polymorphism on the occurrence of coronary artery disease (CAD) and on serum lipids, lipoproteins and…”
    Get more information
    Journal Article
  11. 11

    Broader indication for treatment with statins; the 'heart protection study' by Stalenhoef, A F H, Stuyt, P M J

    Published in Nederlands tijdschrift voor geneeskunde (12-10-2002)
    “…The introduction of statins has been a breakthrough in the treatment of hypercholesterolaemia. Statins are safe and effective in reducing the risk of coronary…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Effects of ketoconazole on plasma lipids and lipoprotein(a) in familial hypercholesterolaemia, compared with simvastatin by Stalenhoef, A F, Stuyt, P M, de Graaf, J

    Published in Netherlands journal of medicine (01-07-1997)
    “…Ketoconazole is an imidazole derivative that is active as a broad-spectrum antifungal agent. It is also an inhibitor of cholesterol production both in vivo and…”
    Get more information
    Journal Article
  17. 17

    Tolerability and effects of high doses acipimox as additional lipid-lowering therapy in familial hypercholesterolemia by Stuyt, P M, Kleinjans, H A, Stalenhoef, A F

    Published in Netherlands journal of medicine (01-11-1998)
    “…Acipimox, a derivative of nicotinic acid, lowers serum lipid levels by reducing the production of very-low-density and low-density lipoproteins (LDL). We…”
    Get more information
    Journal Article
  18. 18

    The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors by Swinkels, D W, Demacker, P N, Hendriks, J C, Brenninkmeijer, B J, Stuyt, P M

    Published in Atherosclerosis (01-05-1989)
    “…The significance of a decreased low density lipoprotein cholesterol/apolipoprotein B ratio (LDL-chol/LDL apo B), or protein-enriched LDL, to predict…”
    Get more information
    Journal Article
  19. 19
  20. 20